Qualitas Health enters strategic partnerships with Grupo Indukern and Gullspång Re:food
Qualitas Health, doing business as iwi, has partnered with Grupo Indukern (, and Gullspång Re:food VC to accelerate company growth through the development of innovative, algae-centered products, and increase its footprint in the plant-based products market.
Photo © iStockphoto.com
Qualitas Health (Houston, TX), doing business as iwi, has partnered with Grupo Indukern (Barcelona, Spain), and Gullspång Re:food VC (Stockholm, Sweden) to accelerate company growth through the development of innovative, algae-centered products, and increase its footprint in the plant-based products market. The partnerships closes Round A funding for Qualitas, and opens direct access for iwi to the investors’ advanced facilities and teams, along with their expertise.
“Qualitas has a great story to tell,” explained Peter Odemark, a Gullspång Re:food managing partner, in a press release. “Its algae is cultivated in impressive pond systems built on nonarable land in the desert, place minimal footprint on the natural ecosystem, harnessing natural sun-power for energy and utilizing saltwater, while creating jobs in rural communities. We share the same values and vision for creating a better future, better nutrition and to protect the planet.”
“Grupo Indukern and Gullspång Re:food are the perfect partners for the current scaling stage,” said Miguel Calatayud, CEO of Qualitas Health. “They bring know-how and expertise, to iwi’s existing supplement business and wider recognition of our newly developed Nannochloropsis algae protein. They also provide a global vision, a distribution platform for Europe and other countries and regions, and unique expertise in plant-based proteins and finished products. Their knowledge, skilled technological team, and advanced technologies will help in conducting clinical research and accelerate the regulatory process for Europe.”
The new algae protein ingredient and product line will be launched in 2022, which iwi says will offer a full complement of essential amino acids and vital nutrients. The ingredient will also be water soluble, with little impact on texture, flavor and aroma. The main markets the protein will target are personalized nutrition, high-performance sports nutrition, and adult nutrition for protein deficiencies.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
